Metastatic Neuroendocrine Tumor with Unknown Primary Site Presenting Simultaneously with Prostate Adenocarcinoma

#2206

Introduction: Neuroendocrine tumors (NET) arise from a variety of different organs and have a steadily increasing incidence in the last 3 decades. 13% of NETs have unknown primary sites.

Aim(s): We present the case of a 65 years old patient recently diagnosed with metastatic G2 NET of unknown primary site.

Materials and methods: In December 2016, prior to surgery for prostate adenocarcinoma, the patient underwent abdominal and pelvic CT exam.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Enache O, Martin S, Lambrescu I, Sirbu A, Constantin T,

Keywords: neuroendocrine, somatostatin analogs,